Trade now with Barclays Stockbrokers
| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| Matthew Moulding |
390,904,588 |
£184,976,051 |
| Charles Allen |
2,942,000 |
£1,392,154 |
| Damian Sanders |
487,487 |
£230,679 |
| Susan Jane Farr |
145,243 |
£68,729 |
| Helen Jones |
134,084 |
£63,448 |
| Gillian Kent |
53,500 |
£25,316 |
| Dean Moore |
53,143 |
£25,147 |
| Frasers Group plc |
172,357,765 |
£81,559,694 |
| Sofina Capital S.A |
127,494,951 |
£60,330,611 |
| Matthew Moulding |
98,596,539 |
£46,655,882 |
| Balderton Capital IV, L.P |
96,947,470 |
£45,875,543 |
| Qatar Investment Authority |
95,148,959 |
£45,024,487 |
| Merian Global Investors |
86,972,130 |
£41,155,212 |
| SB Northstar LP |
80,621,797 |
£38,150,234 |
| Jupiter Fund Management plc |
62,034,208 |
£29,354,587 |
| T. Rowe Price |
60,908,595 |
£28,821,947 |
| 16:35 |
308,615 @ 47.32p |
| 16:35 |
690 @ 47.32p |
| 16:35 |
11,321 @ 47.32p |
| 16:35 |
1,172 @ 47.32p |
| 16:35 |
37 @ 47.32p |
| CEO |
Matthew Moulding |
| CFO |
Damian Sanders |
| Chair |
Charles Allen |
Top of Page
You are here:
research